E M Byrne1,1,2, A F McRae3,3, D L Duffy4, Z Z Zhao4, N G Martin4, J B Whitfield4, P M Visscher3,3, G W Montgomery4. 1. Queensland Statistical Genetics, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD, 4029, Australia. enda.byrne@qimr.edu.au. 2. School of Medicine, University of Queensland, Brisbane, QLD, Australia. enda.byrne@qimr.edu.au. 3. Queensland Statistical Genetics, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, QLD, 4029, Australia. 4. Genetic Epidemiology, Queensland Institute of Medical Research, Brisbane, QLD, Australia.
Abstract
AIMS/HYPOTHESIS: There has been much focus on the potential role of mitochondria in the aetiology of type 2 diabetes and the metabolic syndrome, and many case-control mitochondrial association studies have been undertaken for these conditions. We tested for a potential association between common mitochondrial variants and a number of quantitative traits related to type 2 diabetes in a large sample of >2,000 healthy Australian adolescent twins and their siblings, many of whom were measured on more than one occasion. METHODS: To the best of our knowledge, this is the first mitochondrial association study of quantitative traits undertaken using family data. The maternal inheritance pattern of mitochondria means established association methodologies are unsuitable for analysis of mitochondrial data in families. We present a methodology, implemented in the freely available program Sib-Pair for performing such an analysis. RESULTS: Despite our study having the power to detect variants with modest effects on these phenotypes, only one significant association was found after correction for multiple testing in any of four age groups. This was for mt14365 with triacylglycerol levels (unadjusted p = 0.0006). This association was not replicated in other age groups. CONCLUSIONS/ INTERPRETATION: We find little evidence in our sample to suggest that common European mitochondrial variants contribute to variation in quantitative phenotypes related to diabetes. Only one variant showed a significant association in our sample, and this association will need to be replicated in a larger cohort. Such replication studies or future meta-analyses may reveal more subtle effects that could not be detected here because of limitations of sample size.
AIMS/HYPOTHESIS: There has been much focus on the potential role of mitochondria in the aetiology of type 2 diabetes and the metabolic syndrome, and many case-control mitochondrial association studies have been undertaken for these conditions. We tested for a potential association between common mitochondrial variants and a number of quantitative traits related to type 2 diabetes in a large sample of >2,000 healthy Australian adolescent twins and their siblings, many of whom were measured on more than one occasion. METHODS: To the best of our knowledge, this is the first mitochondrial association study of quantitative traits undertaken using family data. The maternal inheritance pattern of mitochondria means established association methodologies are unsuitable for analysis of mitochondrial data in families. We present a methodology, implemented in the freely available program Sib-Pair for performing such an analysis. RESULTS: Despite our study having the power to detect variants with modest effects on these phenotypes, only one significant association was found after correction for multiple testing in any of four age groups. This was for mt14365 with triacylglycerol levels (unadjusted p = 0.0006). This association was not replicated in other age groups. CONCLUSIONS/ INTERPRETATION: We find little evidence in our sample to suggest that common European mitochondrial variants contribute to variation in quantitative phenotypes related to diabetes. Only one variant showed a significant association in our sample, and this association will need to be replicated in a larger cohort. Such replication studies or future meta-analyses may reveal more subtle effects that could not be detected here because of limitations of sample size.
Authors: Richa Saxena; Paul I W de Bakker; Karyn Singer; Vamsi Mootha; Noel Burtt; Joel N Hirschhorn; Daniel Gaudet; Bo Isomaa; Mark J Daly; Leif Groop; Kristin G Ardlie; David Altshuler Journal: Am J Hum Genet Date: 2006-05-24 Impact factor: 11.025
Authors: P F Chinnery; H R Elliott; S Patel; C Lambert; S M Keers; S E Durham; M I McCarthy; G A Hitman; A T Hattersley; M Walker Journal: Lancet Date: 2005-11-05 Impact factor: 79.321
Authors: Karen L Mohlke; Anne U Jackson; Laura J Scott; Erin C Peck; Yong D Suh; Peter S Chines; Richard M Watanabe; Thomas A Buchanan; Karen N Conneely; Michael R Erdos; Narisu Narisu; Sareena Enloe; Timo T Valle; Jaakko Tuomilehto; Richard N Bergman; Michael Boehnke; Francis S Collins Journal: Hum Genet Date: 2005-11-15 Impact factor: 4.132
Authors: Anne Katrin Detjen; Sigrid Tinschert; Dieter Kaufmann; Bernd Algermissen; Peter Nürnberg; Markus Schuelke Journal: Twin Res Hum Genet Date: 2007-06 Impact factor: 1.587
Authors: Chunyu Liu; Jessica L Fetterman; Poching Liu; Yan Luo; Martin G Larson; Ramachandran S Vasan; Jun Zhu; Daniel Levy Journal: Hum Genet Date: 2018-02-08 Impact factor: 4.132